Skip to content
Disclosery

WuXi AppTec Co., Ltd.

Follow

13F filer, CIK 1832424, Shanghai, China

WuXi AppTec Co., Ltd. reported $38,566,657 across 5 holdings for the quarter ended 2023-12-31, in a 13F-HR filed 2024-02-06.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-24-011099

Period
2023-12-31
Reported value
$38.6M
Holdings
5
Top 10 weight
100%
New
Sold out

Holdings, Q4 2023

Share positions as resolved from 13F-HR 0001104659-24-011099, largest first. % of portfolio is the value over $38,566,657, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
LYELL IMMUNOPHARMA INCLYELL IMMUNOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: not loaded; 2023Q1: not loaded; 2023Q2: not loaded; 2023Q3: not loaded; 2023Q4: 8,180,678 shares 8,180,678$15.9M41.15%
AMBRX BIOPHARMA INCAMBRX BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: not loaded; 2023Q1: not loaded; 2023Q2: not loaded; 2023Q3: not loaded; 2023Q4: 1,000,000 shares 1,000,000$14.2M36.92%
ADAGADAGENE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: not loaded; 2023Q1: not loaded; 2023Q2: not loaded; 2023Q3: not loaded; 2023Q4: 4,225,696 shares 4,225,696$8.16M21.16%Timeline
PURPLE BIOTECH LTD SPONSORE…PURPLE BIOTECH LTD SPONSORED ADRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: not loaded; 2023Q1: not loaded; 2023Q2: not loaded; 2023Q3: not loaded; 2023Q4: 194,139 shares 194,139$151K0.39%
CSTLCASTLE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: not loaded; 2023Q1: not loaded; 2023Q2: not loaded; 2023Q3: not loaded; 2023Q4: 6,636 shares 6,636$143K0.37%Timeline

How Q4 2023 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-24-011099 base2024-02-06acceptance time not in the bulk data set